Terms: = Liver cancer AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK AND Diagnosis
42 results:
1. S100A11 Promotes Metastasis via AKT and erk Signaling Pathways and Has a Diagnostic Role in Hepatocellular Carcinoma.
Zheng M; Meng H; Li Y; Shi J; Han Y; Zhao C; Chen J; Han J; Liang J; Chen Y; Liu Q; Wang Y
Int J Med Sci; 2023; 20(3):318-328. PubMed ID: 36860671
[TBL] [Abstract] [Full Text] [Related]
2. The Prognostic Value and the Oncogenic and Immunological Roles of Vacuolar Protein Sorting Associated Protein 26 A in Pancreatic Adenocarcinoma.
Hou J; Wu H; Xu B; Shang J; Xu X; Li G; Zhang H; Zhang W; Deng Y; Hong X; Hu T; Zhang M; Zhan Y
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834898
[TBL] [Abstract] [Full Text] [Related]
3. N6-Methyladenosine-Mediated Up-Regulation of FZD10 Regulates liver cancer Stem Cells' Properties and Lenvatinib Resistance Through WNT/β-Catenin and Hippo Signaling Pathways.
Wang J; Yu H; Dong W; Zhang C; Hu M; Ma W; Jiang X; Li H; Yang P; Xiang D
Gastroenterology; 2023 May; 164(6):990-1005. PubMed ID: 36764493
[TBL] [Abstract] [Full Text] [Related]
4. Desmocollin-2 inhibits cell proliferation and promotes apoptosis in hepatocellular carcinoma via the erk/c-MYC signaling pathway.
He B; Guo L; Hu Y; Huang H; Wan L; Xu K; Wang F; Wen Z
Aging (Albany NY); 2022 Nov; 14(21):8805-8817. PubMed ID: 36367775
[TBL] [Abstract] [Full Text] [Related]
5. Unique diagnostic challenge in surgery: hepatic abscess versus malignancy.
Govindaraj S; Prakash C; Ananthamurthy A; Govindaraj S
BMJ Case Rep; 2022 Sep; 15(9):. PubMed ID: 36130822
[TBL] [Abstract] [Full Text] [Related]
6. LINC00662: A new oncogenic lncRNA with great potential.
Zhong C; Zhang Q; Zhang M; Qi Y; Duan S
J Cell Physiol; 2022 Feb; 237(2):1105-1118. PubMed ID: 34647332
[TBL] [Abstract] [Full Text] [Related]
7. LncRNA DARS-AS1 aggravates the growth and metastasis of hepatocellular carcinoma via regulating the miR-3200-5p-Cytoskeleton associated protein 2 (CKAP2) axis.
Feng Y; Wei G; Zhang L; Zhou H; Wang W; Guo P; Cheng C; Ji L; Cai Q; Feng Y; Tu H
Bioengineered; 2021 Dec; 12(1):8217-8232. PubMed ID: 34596006
[TBL] [Abstract] [Full Text] [Related]
8. The molecular structure and role of LECT2 or CHM-II in arthritis, cancer, and other diseases.
Zhu S; Bennett S; Li Y; Liu M; Xu J
J Cell Physiol; 2022 Jan; 237(1):480-488. PubMed ID: 34550600
[TBL] [Abstract] [Full Text] [Related]
9. 33-kDa ANXA3 isoform contributes to hepatocarcinogenesis
Guo C; Li N; Dong C; Wang L; Li Z; Liu Q; Ma Q; Greenaway FT; Tian Y; Hao L; Liu S; Sun MZ
J Adv Res; 2021 May; 30():85-102. PubMed ID: 34026289
[TBL] [Abstract] [Full Text] [Related]
10. Primary squamous cell carcinoma of the pancreas with a large pseudocyst of the pancreas as the first manifestation: a rare case report and literature review.
Qiu X; Meng Y; Lu M; Tian C; Wang M; Zhang J
BMC Gastroenterol; 2021 May; 21(1):208. PubMed ID: 33964875
[TBL] [Abstract] [Full Text] [Related]
11. The DNA replication regulator MCM6: An emerging cancer biomarker and target.
Zeng T; Guan Y; Li YK; Wu Q; Tang XJ; Zeng X; Ling H; Zou J
Clin Chim Acta; 2021 Jun; 517():92-98. PubMed ID: 33609557
[TBL] [Abstract] [Full Text] [Related]
12. The CDCP1 Signaling Hub: A Target for cancer Detection and Therapeutic Intervention.
Khan T; Kryza T; Lyons NJ; He Y; Hooper JD
Cancer Res; 2021 May; 81(9):2259-2269. PubMed ID: 33509939
[TBL] [Abstract] [Full Text] [Related]
13. Diagnostic and prognostic values of AKR1C3 and AKR1D1 in hepatocellular carcinoma.
Zhu P; Feng R; Lu X; Liao Y; Du Z; Zhai W; Chen K
Aging (Albany NY); 2021 Jan; 13(3):4138-4156. PubMed ID: 33493134
[TBL] [Abstract] [Full Text] [Related]
14. miR-188-5p inhibits proliferation, migration, and invasion in gallbladder carcinoma by targeting Wnt2b and Smad2.
Li XL; Li SZ; Wu CX; Xing XH
Kaohsiung J Med Sci; 2021 Apr; 37(4):294-304. PubMed ID: 33236530
[TBL] [Abstract] [Full Text] [Related]
15. NQO1 promotes an aggressive phenotype in hepatocellular carcinoma via amplifying erk-NRF2 signaling.
Yang Y; Zheng J; Wang M; Zhang J; Tian T; Wang Z; Yuan S; Liu L; Zhu P; Gu F; Fu S; Shan Y; Pan Z; Zhou W
Cancer Sci; 2021 Feb; 112(2):641-654. PubMed ID: 33222332
[TBL] [Abstract] [Full Text] [Related]
16. Hypoxia-inducible long noncoding RNA NPSR1-AS1 promotes the proliferation and glycolysis of hepatocellular carcinoma cells by regulating the MAPK/erk pathway.
He H; Chen T; Mo H; Chen S; Liu Q; Guo C
Biochem Biophys Res Commun; 2020 Dec; 533(4):886-892. PubMed ID: 33008585
[TBL] [Abstract] [Full Text] [Related]
17. erk1/2 Signaling Induces Upregulation of ANGPT2 and CXCR4 to Mediate liver Metastasis in Colon cancer.
Urosevic J; Blasco MT; Llorente A; Bellmunt A; Berenguer-Llergo A; Guiu M; Cañellas A; Fernandez E; Burkov I; Clapés M; Cartanà M; Figueras-Puig C; Batlle E; Nebreda AR; Gomis RR
Cancer Res; 2020 Nov; 80(21):4668-4680. PubMed ID: 32816905
[TBL] [Abstract] [Full Text] [Related]
18. liver metastatic basaloid squamous cell carcinoma with negative expression of pancytokeratin: a case report and literature review.
Liu L; Xue X; Xue L
Diagn Pathol; 2019 Sep; 14(1):102. PubMed ID: 31488173
[TBL] [Abstract] [Full Text] [Related]
19. Clinicopathological characteristics and molecular abnormalities of primary grade 2 neuroendocrine tumors of the cervix.
Zhu R; Wu H; Chen B; Pang J; Huo Z
Diagn Pathol; 2019 Jun; 14(1):64. PubMed ID: 31228945
[TBL] [Abstract] [Full Text] [Related]
20. HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/erk and PI3K/AKT signaling pathways.
Li Q; Wang C; Wang Y; Sun L; Liu Z; Wang L; Song T; Yao Y; Liu Q; Tu K
J Exp Clin Cancer Res; 2018 Sep; 37(1):231. PubMed ID: 30231922
[TBL] [Abstract] [Full Text] [Related]
[Next]
